Target intelligence / Profile preview

Hemagglutinin antigen of Influenza A H1N1

Molecular classification
Glycoprotein, Viral Surface Antigen
01

Overview

Hemagglutinin (HA) is a glycoprotein found on the surface of the influenza A H1N1 virus. It mediates viral entry into host cells by binding to sialic acid receptors and facilitating fusion between the viral envelope and the host cell membrane. HA is a major antigen and the primary target for neutralizing antibodies, making it crucial for vaccine development. The HA protein is a homotrimer composed of HA1 and HA2 subunits, formed through proteolytic cleavage of a precursor protein. Antigenic drift and shift result in mutations that allow the virus to evade pre-existing immunity, posing a challenge for vaccine effectiveness. Broadly neutralizing antibodies targeting conserved regions of HA are a focus for universal influenza vaccine research.

Other names
HAH1N1 HemagglutininInfluenza A Hemagglutinin
02

Mechanism of action

Receptor binding to sialic acid, membrane fusion mediated by conformational change at low pH.

03

Biological functions

Receptor bindingMembrane fusionImmune response
04

Disease associations

Infection
05

Safety considerations

Antigenic drift and shift leading to vaccine mismatchPotential for antibody-dependent enhancement (ADE)
06

Interacting drugs

Oseltamivir (targets neuraminidase, but relevant in influenza treatment)

4 more in the full profile.

07

Biomarkers

Antibody titers against HemagglutininHemagglutinin sequence variants (for vaccine matching)

Beyond the preview

Go deeper on Hemagglutinin antigen of Influenza A H1N1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin antigen of Influenza A H1N1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call